aluates Reports

$ 0.0

Automative

Global Newborn Screening for SMA and SCID Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-29R13347

Global Newborn Screening for SMA and SCID Market Research Report 2023

BUY CHAPTERS

Global Newborn Screening for SMA and SCID Market Research Report 2025

Code: QYRE-Auto-29R13347

Report

March 2025

Pages:60

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

PerkinElmer Inc

Thermo Fisher

Labsystems Diagnostics

ImmunoIVD

Newborn Screening for SMA and SCID Market Size

The global market for Newborn Screening for SMA and SCID was valued at US$ 165 million in the year 2024 and is projected to reach a revised size of US$ 351 million by 2031, growing at a CAGR of 11.5% during the forecast period.

Newborn Screening for SMA and SCID Market

Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.

Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.

Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.

Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.

This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID.

The Newborn Screening for SMA and SCID market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newborn Screening for SMA and SCID market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Newborn Screening for SMA and SCID companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Newborn Screening for SMA and SCID Market Report

Report Metric	Details
Report Name	Newborn Screening for SMA and SCID Market
Accounted market size in year	US$ 165 million
Forecasted market size in 2031	US$ 351 million
CAGR	11.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Instruments Kits Software
Segment by Application	SCID Screening SMA Screening
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Newborn Screening for SMA and SCID Market growing?

Ans: The Newborn Screening for SMA and SCID Market witnessing a CAGR of 11.5% during the forecast period 2025-2031.

What is the Newborn Screening for SMA and SCID Market size in 2031?

Ans: The Newborn Screening for SMA and SCID Market size in 2031 will be US$ 351 million.

What is the market share of major companies in Newborn Screening for SMA and SCID Market?

Ans: The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share.

What is the Newborn Screening for SMA and SCID Market share by type?

Ans: In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively.

What is the Newborn Screening for SMA and SCID Market share by application?

Ans: In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.

Who are the main players in the Newborn Screening for SMA and SCID Market report?

Ans: The main players in the Newborn Screening for SMA and SCID Market are Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics

What are the Application segmentation covered in the Newborn Screening for SMA and SCID Market report?

Ans: The Applications covered in the Newborn Screening for SMA and SCID Market report are SCID Screening, SMA Screening

What are the Type segmentation covered in the Newborn Screening for SMA and SCID Market report?

Ans: The Types covered in the Newborn Screening for SMA and SCID Market report are Instruments, Kits, Software

Recommended Reports

Newborn Screening

Genetic Testing

Muscular Disease Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Instruments

1.2.3 Kits

1.2.4 Software

1.3 Market by Application

1.3.1 Global Newborn Screening for SMA and SCID Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 SCID Screening

1.3.3 SMA Screening

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Newborn Screening for SMA and SCID Market Perspective (2020-2031)

2.2 Global Newborn Screening for SMA and SCID Growth Trends by Region

2.2.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Newborn Screening for SMA and SCID Historic Market Size by Region (2020-2025)

2.2.3 Newborn Screening for SMA and SCID Forecasted Market Size by Region (2026-2031)

2.3 Newborn Screening for SMA and SCID Market Dynamics

2.3.1 Newborn Screening for SMA and SCID Industry Trends

2.3.2 Newborn Screening for SMA and SCID Market Drivers

2.3.3 Newborn Screening for SMA and SCID Market Challenges

2.3.4 Newborn Screening for SMA and SCID Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Newborn Screening for SMA and SCID Players by Revenue

3.1.1 Global Top Newborn Screening for SMA and SCID Players by Revenue (2020-2025)

3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2020-2025)

3.2 Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Newborn Screening for SMA and SCID Revenue

3.4 Global Newborn Screening for SMA and SCID Market Concentration Ratio

3.4.1 Global Newborn Screening for SMA and SCID Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Newborn Screening for SMA and SCID Revenue in 2024

3.5 Global Key Players of Newborn Screening for SMA and SCID Head office and Area Served

3.6 Global Key Players of Newborn Screening for SMA and SCID, Product and Application

3.7 Global Key Players of Newborn Screening for SMA and SCID, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Newborn Screening for SMA and SCID Breakdown Data by Type

4.1 Global Newborn Screening for SMA and SCID Historic Market Size by Type (2020-2025)

4.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2026-2031)

5 Newborn Screening for SMA and SCID Breakdown Data by Application

5.1 Global Newborn Screening for SMA and SCID Historic Market Size by Application (2020-2025)

5.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Newborn Screening for SMA and SCID Market Size (2020-2031)

6.2 North America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Newborn Screening for SMA and SCID Market Size by Country (2020-2025)

6.4 North America Newborn Screening for SMA and SCID Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Newborn Screening for SMA and SCID Market Size (2020-2031)

7.2 Europe Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Newborn Screening for SMA and SCID Market Size by Country (2020-2025)

7.4 Europe Newborn Screening for SMA and SCID Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Newborn Screening for SMA and SCID Market Size (2020-2031)

8.2 Asia-Pacific Newborn Screening for SMA and SCID Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2020-2025)

8.4 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Newborn Screening for SMA and SCID Market Size (2020-2031)

9.2 Latin America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Newborn Screening for SMA and SCID Market Size by Country (2020-2025)

9.4 Latin America Newborn Screening for SMA and SCID Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Newborn Screening for SMA and SCID Market Size (2020-2031)

10.2 Middle East & Africa Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2020-2025)

10.4 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Perkinelmer

11.1.1 Perkinelmer Company Details

11.1.2 Perkinelmer Business Overview

11.1.3 Perkinelmer Newborn Screening for SMA and SCID Introduction

11.1.4 Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2020-2025)

11.1.5 Perkinelmer Recent Development

11.2 Thermo Fisher

11.2.1 Thermo Fisher Company Details

11.2.2 Thermo Fisher Business Overview

11.2.3 Thermo Fisher Newborn Screening for SMA and SCID Introduction

11.2.4 Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2020-2025)

11.2.5 Thermo Fisher Recent Development

11.3 ImmunoIVD

11.3.1 ImmunoIVD Company Details

11.3.2 ImmunoIVD Business Overview

11.3.3 ImmunoIVD Newborn Screening for SMA and SCID Introduction

11.3.4 ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2020-2025)

11.3.5 ImmunoIVD Recent Development

11.4 Labsystems Diagnostics

11.4.1 Labsystems Diagnostics Company Details

11.4.2 Labsystems Diagnostics Business Overview

11.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Introduction

11.4.4 Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2020-2025)

11.4.5 Labsystems Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

PerkinElmer Inc

Thermo Fisher

Labsystems Diagnostics

ImmunoIVD

List of Tables

Table 1. Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Instruments

Table 3. Key Players of Kits

Table 4. Key Players of Software

Table 5. Global Newborn Screening for SMA and SCID Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Newborn Screening for SMA and SCID Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Newborn Screening for SMA and SCID Market Share by Region (2020-2025)

Table 9. Global Newborn Screening for SMA and SCID Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Newborn Screening for SMA and SCID Market Share by Region (2026-2031)

Table 11. Newborn Screening for SMA and SCID Market Trends

Table 12. Newborn Screening for SMA and SCID Market Drivers

Table 13. Newborn Screening for SMA and SCID Market Challenges

Table 14. Newborn Screening for SMA and SCID Market Restraints

Table 15. Global Newborn Screening for SMA and SCID Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Newborn Screening for SMA and SCID Market Share by Players (2020-2025)

Table 17. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2024)

Table 18. Ranking of Global Top Newborn Screening for SMA and SCID Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Newborn Screening for SMA and SCID Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Newborn Screening for SMA and SCID, Headquarters and Area Served

Table 21. Global Key Players of Newborn Screening for SMA and SCID, Product and Application

Table 22. Global Key Players of Newborn Screening for SMA and SCID, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Newborn Screening for SMA and SCID Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2020-2025)

Table 26. Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2026-2031)

Table 28. Global Newborn Screening for SMA and SCID Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2020-2025)

Table 30. Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2026-2031)

Table 32. North America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Newborn Screening for SMA and SCID Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)

Table 47. Perkinelmer Company Details

Table 48. Perkinelmer Business Overview

Table 49. Perkinelmer Newborn Screening for SMA and SCID Product

Table 50. Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)

Table 51. Perkinelmer Recent Development

Table 52. Thermo Fisher Company Details

Table 53. Thermo Fisher Business Overview

Table 54. Thermo Fisher Newborn Screening for SMA and SCID Product

Table 55. Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)

Table 56. Thermo Fisher Recent Development

Table 57. ImmunoIVD Company Details

Table 58. ImmunoIVD Business Overview

Table 59. ImmunoIVD Newborn Screening for SMA and SCID Product

Table 60. ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)

Table 61. ImmunoIVD Recent Development

Table 62. Labsystems Diagnostics Company Details

Table 63. Labsystems Diagnostics Business Overview

Table 64. Labsystems Diagnostics Newborn Screening for SMA and SCID Product

Table 65. Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)

Table 66. Labsystems Diagnostics Recent Development

Table 67. Research Programs/Design for This Report

Table 68. Key Data Information from Secondary Sources

Table 69. Key Data Information from Primary Sources

Table 70. Authors List of This Report

List of Figures

Figure 1. Newborn Screening for SMA and SCID Picture

Figure 2. Global Newborn Screening for SMA and SCID Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Newborn Screening for SMA and SCID Market Share by Type: 2024 VS 2031

Figure 4. Instruments Features

Figure 5. Kits Features

Figure 6. Software Features

Figure 7. Global Newborn Screening for SMA and SCID Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Newborn Screening for SMA and SCID Market Share by Application: 2024 VS 2031

Figure 9. SCID Screening Case Studies

Figure 10. SMA Screening Case Studies

Figure 11. Newborn Screening for SMA and SCID Report Years Considered

Figure 12. Global Newborn Screening for SMA and SCID Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Newborn Screening for SMA and SCID Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Newborn Screening for SMA and SCID Market Share by Region: 2024 VS 2031

Figure 15. Global Newborn Screening for SMA and SCID Market Share by Players in 2024

Figure 16. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Newborn Screening for SMA and SCID Revenue in 2024

Figure 18. North America Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Newborn Screening for SMA and SCID Market Share by Country (2020-2031)

Figure 20. United States Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Newborn Screening for SMA and SCID Market Share by Country (2020-2031)

Figure 24. Germany Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Newborn Screening for SMA and SCID Market Share by Region (2020-2031)

Figure 32. China Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Newborn Screening for SMA and SCID Market Share by Country (2020-2031)

Figure 40. Mexico Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Newborn Screening for SMA and SCID Market Share by Country (2020-2031)

Figure 44. Turkey Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Perkinelmer Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)

Figure 48. Thermo Fisher Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)

Figure 49. ImmunoIVD Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)

Figure 50. Labsystems Diagnostics Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Newborn Genetic Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Newborn Screening and Genetic Services Market Research Report 2024

Prenatal Testing and Newborn Screening Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Newborn Disease Screening Market Research Report 2025

Newborn Screening Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Newborn Metabolic Screening Market Research Report 2024

Global Newborn Screening Program Market Research Report 2024

Global Newborn and Prenatal Genetic Testing Market Insights Forecast to 2030

Global Newborn Screening Instruments Market Insights Forecast to 2030

Global New Born Screening Market Research Report 2024

Global Prenatal Testing and Newborn Screening Market Research Report 2024

Medical Newborn Screening Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neonatal Genetic Disease Diagnosis Market Research Report 2024

Global Neonatal Hearing Screening Devices Market Research Report 2024

Global Antenatal Screening Market Research Report 2024

Newborn Genetic Screening Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prenatal Genetic Screening Test Market Research Report 2024

Pediatric Genetic Testing Market

Global New Born Eye Imaging Systems Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions